JPS56100714A - Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane - Google Patents
Pharmaceutical adhering to oral mucous membrane or nasal mucous membraneInfo
- Publication number
- JPS56100714A JPS56100714A JP252280A JP252280A JPS56100714A JP S56100714 A JPS56100714 A JP S56100714A JP 252280 A JP252280 A JP 252280A JP 252280 A JP252280 A JP 252280A JP S56100714 A JPS56100714 A JP S56100714A
- Authority
- JP
- Japan
- Prior art keywords
- mucous membrane
- pharmaceutical
- adhering
- drug
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004400 mucous membrane Anatomy 0.000 title abstract 8
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
- 102000004877 Insulin Human genes 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 229920002125 Sokalan® Polymers 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 2
- 239000011247 coating layer Substances 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 229940125396 insulin Drugs 0.000 abstract 2
- 239000010410 layer Substances 0.000 abstract 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
- 229920003086 cellulose ether Polymers 0.000 abstract 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003883 ointment base Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP252280A JPS56100714A (en) | 1980-01-16 | 1980-01-16 | Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP252280A JPS56100714A (en) | 1980-01-16 | 1980-01-16 | Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56100714A true JPS56100714A (en) | 1981-08-12 |
| JPS6323964B2 JPS6323964B2 (enExample) | 1988-05-18 |
Family
ID=11531701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP252280A Granted JPS56100714A (en) | 1980-01-16 | 1980-01-16 | Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS56100714A (enExample) |
Cited By (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5989619A (ja) * | 1982-10-05 | 1984-05-23 | サンド・アクチエンゲゼルシヤフト | カルシトニン組成物およびその用途 |
| JPS59232553A (ja) * | 1983-06-16 | 1984-12-27 | 日東電工株式会社 | 粘膜包帯 |
| JPS59232552A (ja) * | 1983-06-16 | 1984-12-27 | 日東電工株式会社 | 粘膜包帯 |
| US4517173A (en) * | 1980-09-26 | 1985-05-14 | Nippon Soda Co. Ltd. | Mucous membrane-adhering film preparation and process for its preparation |
| US4569837A (en) * | 1983-06-01 | 1986-02-11 | Teijin Limited | Pharmaceutical preparation for remedy of periodontal disease and process for production thereof |
| US4572832A (en) * | 1982-10-07 | 1986-02-25 | Grelan Pharmaceutical Co., Ltd. | Soft buccal |
| JPS61282320A (ja) * | 1985-06-04 | 1986-12-12 | サンド・アクチエンゲゼルシヤフト | 鼻腔用医薬組成物 |
| JPS63310818A (ja) * | 1987-06-12 | 1988-12-19 | Sato Seiyaku Kk | シ−ト状口腔粘膜付着製剤 |
| JPH01279839A (ja) * | 1988-04-30 | 1989-11-10 | Nitto Denko Corp | 水溶性生理活性蛋白質製剤 |
| JPH02262526A (ja) * | 1982-10-05 | 1990-10-25 | Sandoz Ag | カルシトニン組成物およびその用途 |
| US5122127A (en) * | 1985-05-01 | 1992-06-16 | University Of Utah | Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues |
| US5132114A (en) * | 1985-05-01 | 1992-07-21 | University Of Utah Research Foundation | Compositions and methods of manufacture of compressed powder medicaments |
| US5364634A (en) * | 1991-11-08 | 1994-11-15 | Southwest Research Institute | Controlled-release PH sensitive capsule and adhesive system and method |
| US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
| US5955097A (en) * | 1996-10-18 | 1999-09-21 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
| WO2000001416A1 (en) * | 1998-07-07 | 2000-01-13 | Yissum Research Developing Company Of The Hebrew University Of Jerusalem | Pharmaceutical compositions containing low-melting waxes |
| US6103266A (en) * | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
| JP2001131057A (ja) * | 1999-08-26 | 2001-05-15 | Takeda Chem Ind Ltd | 鼻粘膜付着マトリックス |
| EP1123696A4 (en) * | 1998-09-25 | 2002-02-06 | Kao Corp | COMPOSITIONS FOR ORAL CAVITY |
| US6432415B1 (en) | 1999-12-17 | 2002-08-13 | Axrix Laboratories, Inc. | Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| JP2009535304A (ja) * | 2006-04-13 | 2009-10-01 | オラヘルス コーポレーション | 口内温度にて水溶性であるグリシルレチン酸の塩を含んだ口内パッチ |
| US8173113B1 (en) | 1989-11-03 | 2012-05-08 | 3M Innovative Properties Company | Bioadhesive composition and patch |
| US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
| US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
| US8906277B2 (en) | 2001-10-12 | 2014-12-09 | Monosol Rx, Llc | Process for manufacturing a resulting pharmaceutical film |
| JP2015519403A (ja) * | 2012-06-14 | 2015-07-09 | エントレガ，インコーポレイテッド | 活性剤送達のための粘膜付着性デバイス |
| US9108340B2 (en) | 2001-10-12 | 2015-08-18 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
| US9597288B2 (en) | 2006-07-21 | 2017-03-21 | Biodelivery Sciences International, Inc. | Transmucosal delivery devices with enhanced uptake |
| US9855221B2 (en) | 2001-10-12 | 2018-01-02 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
| US9931305B2 (en) | 2001-10-12 | 2018-04-03 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| US10272607B2 (en) | 2010-10-22 | 2019-04-30 | Aquestive Therapeutics, Inc. | Manufacturing of small film strips |
| US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
| US10821074B2 (en) | 2009-08-07 | 2020-11-03 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
| US11077068B2 (en) | 2001-10-12 | 2021-08-03 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US11191737B2 (en) | 2016-05-05 | 2021-12-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
| US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| JP2022166793A (ja) * | 2021-04-21 | 2022-11-02 | 順也 藤森 | フィトケミカル組成物 |
| US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
| US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
| US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
| US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
| US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
| US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
| US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US12246043B2 (en) | 2013-12-20 | 2025-03-11 | Seed Health, Inc. | Topical application to treat acne vulgaris |
| US12257272B2 (en) | 2015-12-24 | 2025-03-25 | Seed Health, Inc. | Method and system for reducing the likelihood of developing depression in an individual |
| US12279989B2 (en) | 2011-02-04 | 2025-04-22 | Seed Health, Inc. | Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity |
| US12329783B2 (en) | 2013-12-20 | 2025-06-17 | Seed Health, Inc. | Method and system to improve the health of a person's skin microbiome |
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| US12465564B2 (en) | 2021-10-25 | 2025-11-11 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
-
1980
- 1980-01-16 JP JP252280A patent/JPS56100714A/ja active Granted
Cited By (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4517173A (en) * | 1980-09-26 | 1985-05-14 | Nippon Soda Co. Ltd. | Mucous membrane-adhering film preparation and process for its preparation |
| JPH02262526A (ja) * | 1982-10-05 | 1990-10-25 | Sandoz Ag | カルシトニン組成物およびその用途 |
| JPS5989619A (ja) * | 1982-10-05 | 1984-05-23 | サンド・アクチエンゲゼルシヤフト | カルシトニン組成物およびその用途 |
| US4572832A (en) * | 1982-10-07 | 1986-02-25 | Grelan Pharmaceutical Co., Ltd. | Soft buccal |
| US4569837A (en) * | 1983-06-01 | 1986-02-11 | Teijin Limited | Pharmaceutical preparation for remedy of periodontal disease and process for production thereof |
| JPS59232553A (ja) * | 1983-06-16 | 1984-12-27 | 日東電工株式会社 | 粘膜包帯 |
| JPS59232552A (ja) * | 1983-06-16 | 1984-12-27 | 日東電工株式会社 | 粘膜包帯 |
| US5122127A (en) * | 1985-05-01 | 1992-06-16 | University Of Utah | Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues |
| US5132114A (en) * | 1985-05-01 | 1992-07-21 | University Of Utah Research Foundation | Compositions and methods of manufacture of compressed powder medicaments |
| JPS61282320A (ja) * | 1985-06-04 | 1986-12-12 | サンド・アクチエンゲゼルシヤフト | 鼻腔用医薬組成物 |
| JPS63310818A (ja) * | 1987-06-12 | 1988-12-19 | Sato Seiyaku Kk | シ−ト状口腔粘膜付着製剤 |
| JPH01279839A (ja) * | 1988-04-30 | 1989-11-10 | Nitto Denko Corp | 水溶性生理活性蛋白質製剤 |
| US8173113B1 (en) | 1989-11-03 | 2012-05-08 | 3M Innovative Properties Company | Bioadhesive composition and patch |
| US5364634A (en) * | 1991-11-08 | 1994-11-15 | Southwest Research Institute | Controlled-release PH sensitive capsule and adhesive system and method |
| US5955097A (en) * | 1996-10-18 | 1999-09-21 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
| US6159498A (en) * | 1996-10-18 | 2000-12-12 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds of mucosal surfaces |
| US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
| US6290984B1 (en) | 1996-10-18 | 2001-09-18 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
| US7579019B2 (en) | 1996-10-18 | 2009-08-25 | Arius Two, Inc. | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| US6103266A (en) * | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
| WO2000001416A1 (en) * | 1998-07-07 | 2000-01-13 | Yissum Research Developing Company Of The Hebrew University Of Jerusalem | Pharmaceutical compositions containing low-melting waxes |
| EP1123696A4 (en) * | 1998-09-25 | 2002-02-06 | Kao Corp | COMPOSITIONS FOR ORAL CAVITY |
| JP2001131057A (ja) * | 1999-08-26 | 2001-05-15 | Takeda Chem Ind Ltd | 鼻粘膜付着マトリックス |
| US6432415B1 (en) | 1999-12-17 | 2002-08-13 | Axrix Laboratories, Inc. | Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| US9108340B2 (en) | 2001-10-12 | 2015-08-18 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
| US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
| US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
| US8906277B2 (en) | 2001-10-12 | 2014-12-09 | Monosol Rx, Llc | Process for manufacturing a resulting pharmaceutical film |
| US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
| US11077068B2 (en) | 2001-10-12 | 2021-08-03 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
| US9855221B2 (en) | 2001-10-12 | 2018-01-02 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US10888499B2 (en) | 2001-10-12 | 2021-01-12 | Aquestive Therapeutics, Inc. | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| US9931305B2 (en) | 2001-10-12 | 2018-04-03 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| US10111810B2 (en) | 2002-04-11 | 2018-10-30 | Aquestive Therapeutics, Inc. | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| JP2009535304A (ja) * | 2006-04-13 | 2009-10-01 | オラヘルス コーポレーション | 口内温度にて水溶性であるグリシルレチン酸の塩を含んだ口内パッチ |
| US9655843B2 (en) | 2006-07-21 | 2017-05-23 | Biodelivery Sciences International, Inc. | Transmucosal delivery devices with enhanced uptake |
| US9597288B2 (en) | 2006-07-21 | 2017-03-21 | Biodelivery Sciences International, Inc. | Transmucosal delivery devices with enhanced uptake |
| US10821074B2 (en) | 2009-08-07 | 2020-11-03 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
| US10940626B2 (en) | 2010-10-22 | 2021-03-09 | Aquestive Therapeutics, Inc. | Manufacturing of small film strips |
| US10272607B2 (en) | 2010-10-22 | 2019-04-30 | Aquestive Therapeutics, Inc. | Manufacturing of small film strips |
| US12279989B2 (en) | 2011-02-04 | 2025-04-22 | Seed Health, Inc. | Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity |
| US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
| US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
| JP2015519403A (ja) * | 2012-06-14 | 2015-07-09 | エントレガ，インコーポレイテッド | 活性剤送達のための粘膜付着性デバイス |
| US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
| US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
| US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
| US12318414B2 (en) | 2013-12-20 | 2025-06-03 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
| US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
| US12329783B2 (en) | 2013-12-20 | 2025-06-17 | Seed Health, Inc. | Method and system to improve the health of a person's skin microbiome |
| US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US12318411B2 (en) | 2013-12-20 | 2025-06-03 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US12246043B2 (en) | 2013-12-20 | 2025-03-11 | Seed Health, Inc. | Topical application to treat acne vulgaris |
| US12357662B2 (en) | 2013-12-20 | 2025-07-15 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US12257272B2 (en) | 2015-12-24 | 2025-03-25 | Seed Health, Inc. | Method and system for reducing the likelihood of developing depression in an individual |
| US12023309B2 (en) | 2016-05-05 | 2024-07-02 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| US11191737B2 (en) | 2016-05-05 | 2021-12-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| JP2022166793A (ja) * | 2021-04-21 | 2022-11-02 | 順也 藤森 | フィトケミカル組成物 |
| US12465564B2 (en) | 2021-10-25 | 2025-11-11 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6323964B2 (enExample) | 1988-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS56100714A (en) | Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane | |
| JPS53113008A (en) | Constant rate releasing preparation | |
| DK19392A (da) | Komprimerede pulverlaegemidler | |
| IT7951122A0 (it) | Preparato farmaceutico contenente un agente polimerico per rilasciare acido 5-amminosalicilico e suoi sali nel tratto gastrointestinale,eprocedimento di preparazione | |
| ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| NZ509028A (en) | Stable extended release oral dosage composition comprising a pseudoephedrine-containing core, the core being uniformly covered with a desloratadine-containing film | |
| FI842294A0 (fi) | Nya galeniska preparatformer foer orala antidiabetmedel och foerfarande foer deras framstaellning. | |
| NZ218734A (en) | Tablets containing coated microspheres which contain ibuprofen (2-(4-isobutyl phenyl)propanoic acid) | |
| IT8220758A1 (it) | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli | |
| HUT54990A (en) | Process for producing cyclic substituted (quinolin-2-yl-methoxy)-phenyl acetic acid derivatives and pharmaceutical compositions containing them | |
| JPS5551020A (en) | Remedy for rheumatism | |
| JPS56138111A (en) | Suppository containing unsaturated fatty acid or salt thereof | |
| WO2000026185A3 (en) | Omeprazole solution and method of using same | |
| JPS54138126A (en) | Remedy for diabetes | |
| JPS5244222A (en) | Method of making insulin preparations for rectal application | |
| JPS55122715A (en) | Antidiabetic agent | |
| JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
| ES8502111A1 (es) | Un procedimiento de preparacion de diniflumato del ester morfolinoetilico del acido niflumico | |
| JPS5661311A (en) | Thial amide or prolonged pharmaceutical preparation comprising its salt | |
| GR1002731B (el) | Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες. | |
| JPS56138115A (en) | Suppository containing acidic amino acid or derivative thereof | |
| JPS53130421A (en) | Remedy for uterine cancer and its preparation | |
| JPS54126722A (en) | Slow release antibiotic tablet | |
| JPS5326317A (en) | Composition containing n4-acylcytosine arabinoside | |
| RU94040242A (ru) | Способ лечения туберкулеза |